Healthcare -
Biotechnology - NASDAQ - US
$ 9.02
2.85 %
$ 446 M
Market Cap
-2.45
P/E
KALV - CASH FROM INVESTING ACTIVITIES
Cash from Investing Activities KALV - KalVista Pharmaceuticals, Inc.
-84.7 M
LAST VALUE
-56.98%
2 YEAR CAGR
-4.06%
5 YEAR CAGR
-132.95%
10 YEAR CAGR